BlackRock
NVO

BlackRock’s Novo Nordisk NVO Stock Holding History

BlackRock’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-560,000
Closed -$79.9M – 5291
2024
Q2 		$79.9M Sell
560,000
-560,000
-50% -$74.2M ﹤0.01% 2159
2024
Q1 		$144M Buy
+1,120,000
New +$133M ﹤0.01% 1848

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock's NVO Position: Q2 2026 in Review

BlackRock increased its Novo Nordisk (NVO) stake by 31% in Q2 2026, buying an estimated $39.1M and bringing the position to 3,861,182 shares worth $185M. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

BlackRock first reported a position in NVO in Q2 2016 and has held it in 41 quarters since. The position peaked at $780M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • BlackRock held 3,861,182 shares of Novo Nordisk worth $185M as of Q2 2026.
  • BlackRock bought 909,829 Novo Nordisk shares in Q2 2026, an estimated $39.1M.
  • Novo Nordisk made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1841 holding.
  • BlackRock first reported a position in Novo Nordisk in Q2 2016 and has held it in 41 quarters since.
  • BlackRock's Novo Nordisk position peaked at $780M in Q2 2024.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.